InvestorsHub Logo

ShortsRClowns

10/12/21 12:56 PM

#3376 RE: ShortsRClowns #3375

Even after NIH commentary on Tempol and current Tempol/Covid study underway along with its long safety history barely anyone mentions Tempol or Adamis in any articles about treatments against Covid.

We are being told Tempol is the holy grail and yet no one touches, a bit strange. Journalist don't cover and we are being told that doesn't matter b/c they aren't scientist or something like that.